Paratek Pharmaceuticals, Inc. - 10-Q filing on 2016-11-02

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2016

Schedule of Financial Assets and Liabilities Measured at Fair Value

Fair values determined by Level 2 inputs utilize observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities or other inputs that are observable market data. Fair values determined by Level 3 inputs utilize unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability (in thousands):

Description	Total		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
September 30, 2016
Assets:
U.S. treasury securities	$	55,103	$	55,103	$	—	$	—
Government agencies	$	12,751		—		12,751		—
Total Assets	$	67,854	$	55,103	$	12,751	$	—
Liabilities:
Contingent obligations	$	950	$	—	$	—	$	950
Total Liabilities	$	950	$	—	$	—	$	950
December 31, 2015
Liabilities:
Contingent obligations	$	1,000	$	—	$	—	$	1,000
Total Liabilities	$	1,000	$	—	$	—	$	1,000

Rollforward of Fair Value of Contingent Obligations

The following table provides a roll forward of the fair value of contingent obligations categorized as Level 3 instruments, for the nine months ended September 30, 2016 (in thousands):

	Contingent liability— former Transcept stockholders
Balances at December 31, 2015	$	1,000
Change in fair value		(50	)
Balances at September 30, 2016	$	950